BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 34143917)

  • 1. Trimethoprim/sulfamethoxazole for nocardiosis in solid organ transplant recipients: Real-life data from a multicentre retrospective study.
    Conan PL; Matignon M; Bleibtreu A; Guillot H; Van Laecke S; Brenier H; Crochette R; Melica G; Fernández-Ruiz M; Dantal J; Walti LN; Levi C; Chauvet C; De Greef J; Marbus SD; Mueller NJ; Ieven M; Vuotto F; Lortholary O; Coussement J; Lebeaux D
    Transpl Infect Dis; 2021 Aug; 23(4):e13669. PubMed ID: 34143917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethoprim-sulfamethoxazole significantly reduces the risk of nocardiosis in solid organ transplant recipients: systematic review and individual patient data meta-analysis.
    Passerini M; Nayfeh T; Yetmar ZA; Coussement J; Goodlet KJ; Lebeaux D; Gori A; Mahmood M; Temesgen Z; Murad MH
    Clin Microbiol Infect; 2024 Feb; 30(2):170-177. PubMed ID: 37865337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 20-year experience with nocardiosis in solid organ transplant (SOT) recipients in the Southwestern United States: A single-center study.
    Majeed A; Beatty N; Iftikhar A; Mushtaq A; Fisher J; Gaynor P; Kim JC; Marquez JL; Mora FE; Georgescu A; Zangeneh T
    Transpl Infect Dis; 2018 Aug; 20(4):e12904. PubMed ID: 29668074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and prophylaxis for nocardiosis in solid organ transplant recipients: A nested case-control study.
    Yetmar ZA; Chesdachai S; Duffy D; Smith BH; Challener DW; Seville MT; Bosch W; Beam E
    Clin Transplant; 2023 Sep; 37(9):e15016. PubMed ID: 37170686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent nocardiosis in solid organ transplant recipients: An evaluation of secondary prophylaxis.
    Yetmar ZA; Wilson JW; Beam E
    Transpl Infect Dis; 2021 Dec; 23(6):e13753. PubMed ID: 34724316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of transplant recipients with pretransplant Nocardia colonization or infection.
    Yetmar ZA; Chesdachai S; Khodadadi RB; McHugh JW; Challener DW; Wengenack NL; Bosch W; Seville MT; Beam E
    Transpl Infect Dis; 2023 Oct; 25(5):e14097. PubMed ID: 37378539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
    Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
    Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonamide desensitization in solid organ transplant recipients: A protocol-driven approach during the index transplant hospitalization.
    Pryor JB; Olyaei AJ; Kirsch D; Strasfeld L
    Transpl Infect Dis; 2019 Dec; 21(6):e13191. PubMed ID: 31596538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative pneumocystis prophylaxis in solid organ transplant recipients at two large transplant centers.
    Lum J; Echenique I; Athans V; Koval CE
    Transpl Infect Dis; 2021 Feb; 23(1):e13461. PubMed ID: 32894607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study.
    Coussement J; Lebeaux D; van Delden C; Guillot H; Freund R; Marbus S; Melica G; Van Wijngaerden E; Douvry B; Van Laecke S; Vuotto F; Tricot L; Fernández-Ruiz M; Dantal J; Hirzel C; Jais JP; Rodriguez-Nava V; Lortholary O; Jacobs F;
    Clin Infect Dis; 2016 Aug; 63(3):338-45. PubMed ID: 27090987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocardia prophylaxis, treatment, and outcomes of infection in lung transplant recipients: A matched case-control study.
    Goodlet KJ; Tokman S; Nasar A; Cherrier L; Walia R; Nailor MD
    Transpl Infect Dis; 2021 Apr; 23(2):e13478. PubMed ID: 32989873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocardiosis following hematopoietic stem cell transplantation.
    Shannon K; Pasikhova Y; Ibekweh Q; Ludlow S; Baluch A
    Transpl Infect Dis; 2016 Apr; 18(2):169-75. PubMed ID: 26809666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
    Wang EH; Partovi N; Levy RD; Shapiro RJ; Yoshida EM; Greanya ED
    Transpl Infect Dis; 2012 Oct; 14(5):519-25. PubMed ID: 22571389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocardia infections in the transplanted host.
    Hemmersbach-Miller M; Stout JE; Woodworth MH; Cox GM; Saullo JL
    Transpl Infect Dis; 2018 Aug; 20(4):e12902. PubMed ID: 29668123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients.
    Poonyagariyagorn HK; Gershman A; Avery R; Minai O; Blazey H; Asamoto K; Alster J; Murthy S; Mehta A; Pettersson G; Mason DP; Budev M
    Transpl Infect Dis; 2008 Dec; 10(6):403-8. PubMed ID: 18823356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
    Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
    BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
    Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
    Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.
    Werbel WA; Ison MG; Angarone MP; Yang A; Stosor V
    Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
    Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia in adult recipients of kidney transplantation: a real-world data study.
    Chen RY; Li DW; Wang JY; Zhuang SY; Wu HY; Wu JJ; Qu JW; Sun N; Zhong C; Zhu C; Zhang M; Yu YT; Yuan XD
    Int J Infect Dis; 2022 Dec; 125():209-215. PubMed ID: 36243280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.